Biomarin Pharmaceutical Inc (BMRN)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 484,214 | 185,774 | 160,974 | -82,341 | -43,440 |
| Revenue | US$ in thousands | 2,853,920 | 2,419,230 | 2,096,040 | 1,846,280 | 1,860,460 |
| Operating profit margin | 16.97% | 7.68% | 7.68% | -4.46% | -2.33% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $484,214K ÷ $2,853,920K
= 16.97%
Based on the data provided, Biomarin Pharmaceutical Inc has shown fluctuations in its operating profit margin over the past five years. Beginning with a negative operating profit margin of -2.38% in December 2020, the company experienced a further decline to -4.49% by December 2021. However, there was a notable turnaround in the company's performance as the operating profit margin improved to 7.23% in December 2022 and further increased to 7.82% by December 2023. The most significant improvement was observed in December 2024, with a significant jump to an operating profit margin of 17.02%.
These fluctuations in the operating profit margin suggest that Biomarin Pharmaceutical Inc has made strides in improving its operational efficiency and cost management over the years, leading to more profitable operations. This positive trend in the company's operating profit margin indicates that Biomarin Pharmaceutical Inc has been successful in enhancing its profitability levels and generating more value from its operations.
Peer comparison
Dec 31, 2024